A Rare Case of Rheumatoid Arthritis with Tocilizumab-induced Intestinal Mucosal Injury-Reference-Cited by-同舟云学术

A Rare Case of Rheumatoid Arthritis with Tocilizumab-induced Intestinal Mucosal Injury

Published:2022 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ohkubo Akito¹,Osoegawa Takashi¹,Harada Naohiko¹,Iboshi Yoichiro¹,Sumida Yorinobu¹,Nakamuta Makoto¹,Suematsu Eiichi²,Kobayashi Hiroyuki³,Ihara Eikichi⁴

Affiliation:

1. Department of Gastroenterology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan

2. Department of Rheumatology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan

3. Department of Gastroenterology, Fukuoka Sanno Hospital, Japan

4. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_8031-21/_pdf

Reference13 articles.

1. 1. Kishimoto T. Interleukin-6: from basic science to medicine -40 years in immunology. Annu Rev Immunol 23: 1-21, 2005.

2. 2. Nishimoto N. Clinical studies in patient with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan. Clin Rev Allergy Immunol 28: 221-230, 2005.

3. 3. Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritis. Arthritis Rheum 31: 784-788, 1988.

4. 4. Nishimoto N, Kishimoto T. Humanized antihuman IL-6 receptor antibody, tocilizumab. Handb Exp Pharmacol 181: 151-160, 2008.

5. 5. Ogata A, Kato Y, Higa S, Yoshizaki K. IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review. Modern Rheumatology 29: 258-267, 2019.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tocilizumab-induced mucosal injury in the terminal ileum mimicking intestinal Behçet’s disease: A case report;Medicine;2023-06-23

2. Tocilizumab;Reactions Weekly;2022-04